總主編：

張伯禮，生于1948年，中國工程院院士，中醫(yī)內(nèi)科專家，全國名中醫(yī)，國家重點學科中醫(yī)內(nèi)科學學科帶頭人�，F(xiàn)任天津中醫(yī)藥大學校長，中國中醫(yī)科學院名譽院長，國家重大新藥專項技術副總師，國務院醫(yī)改咨詢專家委員會委員，教育部醫(yī)學教育專家委員會副主任，中國藥典委員會副主任委員，世界中醫(yī)藥學會聯(lián)合會教育指導委員會會長。兼任中國中西醫(yī)結合學會名譽會長、中華中醫(yī)藥學會副會長、中華醫(yī)學會副會長、世界中醫(yī)藥學會聯(lián)合會副主席。

?? 幾十年來，主要從事心腦血管疾病中西醫(yī)結合防治和中醫(yī)藥現(xiàn)代化研究。開展血管性癡呆（VD）研究，制定了VD證類分型標準和按平臺、波動及下滑三期證治方案；明確了中風病證候和先兆癥動態(tài)演變規(guī)律，建立了綜合治療方案；創(chuàng)立了腦脊液藥理學方法，揭示中藥對神經(jīng)細胞保護作用機制；完成了首例中藥對冠心病二級預防大規(guī)模循證研究，建立了中醫(yī)藥循證評價系列方法。三次擔任國家“973”計劃項目首席科學家，提出效應配伍理論和以組分配伍研制現(xiàn)代中藥的關鍵技術；開拓中成藥二次開發(fā)研究領域，培育了中藥大品種群；倡導中藥智能制造推動了中藥產(chǎn)業(yè)技術升級。

獲得包括國家科學技術進步一等獎在內(nèi)的國家獎7項，省部級科學技術進步一等獎10項，發(fā)表論文350余篇，出版專著30余部。培養(yǎng)畢業(yè)研究生約260余名。所指導的3篇博士論文獲全國百篇優(yōu)秀博士論文，2篇獲全國百篇優(yōu)秀博士論文提名榮譽。

學風嚴謹，富于創(chuàng)新，形成了采用現(xiàn)代科學技術研究中醫(yī)藥學的突出特色，取得一批重要成果，貢獻突出，成績卓著。1991年起享受國務院頒發(fā)的政府特殊津貼。被授予全國優(yōu)秀共產(chǎn)黨員（2011）、全國先進工作者（2005）、全國優(yōu)秀科技工作者（2001）、國家“ji”有突出貢獻中青年專家（1991）等榮譽稱號，獲何梁何利獎（2006）、吳階平醫(yī)學獎（2015）及中醫(yī)藥國際貢獻獎（2010）等榮譽。

Dr. Zhang Bo-li is an academician and a China-renowned specialist and academic leader in Chinese internal medicine, a national key discipline (recognized as important and receiving support by the Chinese government). He is currently the President of the Tianjin University of Traditional Chinese Medicine and the China Academy of Chinese Medical Sciences. He is also the Deputy Chief Engineer of the National Major Scientific and Technological Special Project for \"Significant New Drugs Development\", a member of the Medical Reform Advisory Committee of the State Council, Vice Committee Director of the Pharmacopoeia Committee, Director of the National Chinese Medicine Teaching Advisory Board of the Ministry of Education and Director of the Educational Instruction Committee of the World Federation of Chinese Medicine Societies. Moreover, he holds concurrent posts such as Honorary President of the China Association of Integrative Medicine, Vice President of the China Association of Traditional Chinese Medicine and Vice President of the World Federation of Chinese Medicine Societies.

For decades, Dr. Zhang has been devoted to the prevention and treatment of cardiovascular and cerebrovascular diseases by integrating traditional Chinese medicine with western medicine, and to the modernization of Chinese medicine (CM). He carried out studies on vascular dementia (VD) and formulated the classification criteria for VD patterns and a treatment scheme based on three phases, i.e., stable, fluctuating and aggravated phases. He specified the patterns and manifestations of stroke as well as the dynamic progression of its premonitory symptoms, and developed a comprehensive therapeutic schedule. He created the pharmacological method of cerebrospinal fluid (CSF) and demonstrated the protective effect of Chinese medicinals on nerve cells and the relevant mechanisms. He completed the first large-scale evidence-based study on the secondary prevention of coronary heart disease with Chinese medicinals, and developed a series of methods for evidence-based evaluation on CM. He served as Chief Scientist of the National Program on Key Basic Research Project of China (973 Program) for three consecutive terms and developed the theory of effect-based compatibility as well as the critical technology for the research and development of modern Chinese medicinals through component-based compatibility. He expanded the research field of the secondary development of Chinese patent medicine which introduced a large group of mass market medicines, and initiated the intelligent manufacturing of Chinese medicinals which promoted the technological upgrading of CM industry.

Dr. Zhang has won 7 national awards (including the first prize for national progress in science and technology) and 10 first-prize provincial and ministerial awards for progress in science and technology. He has published more than 350 papers and over 30 monographs or textbooks. He has mentored and cultivated more than 200 postgraduates.

Dr. Zhang is widely recognized for his prominent contributions in advancing CM. Since 1991, he has been granted a special government allowance by the State Council. He has been conferred with many honorary titles and awards, including National Advanced Worker (2005), Outstanding Scientific and Technological Worker (2001) and National Young and Middle-aged Expert with Outstanding Contribution (1991) as well as the Ho Leung Ho Lee Prize (2006), Wu Jie-ping Medical Research Award (2015) and International Award for Outstanding Contribution to Chinese Medicine (2010).

世界中醫(yī)藥學會聯(lián)合會教育指導委員會簡介

A Brief Introduction to the Educational Instruction Committee of the World Federation of Chinese Medicine Societies

The Educational Instruction Committee (EIC) of the World Federation of Chinese Medicine Societies (WFCMS) is an international advisory, decision-making, and guiding institution concerning Chinese Medicine (CM) education under WFCMS. It carries out important work and research on international CM education, consultancy and coordination, and its headquarters are located in Tianjin, P. R. China (Tianjin University of Traditional Chinese Medicine). The secretariat is the standing office of EIC.

The purposes of the EIC are to increase understanding between international regions and CM educational institutions, to advocate exchanges and cooperation within CM educational communities, to improve the level of CM education, and to promote the CM education industry, in order to make a greater contribution to world CM personnel training.

The mission of the EIC is to generalize the standardization of international CM education; to promote and ensure a healthy and well-ordered development of CM education in various countries/regions according to the international industry standard of CM education released by WFCMS; and to convene international academic conferences, symposia and exhibitions.

The mission also is to set up a website on international CM education and provide consultancies and information services; to construct a platform of international exchanges and advocate the unique features and domination of various countries/regions; to strengthen exchanges and cooperation among CM educational institutions from different countries/regions; to publish academic articles on CM education and research; to study the rules and experiences about CM education in respective countries/regions, to encourage CM educational reform and innovations, and to study international CM education.

In order to improve CM education in the world, the EIC organizes international CM education training, teacher training, teacher exchanges, further education, and remote education. It actively cooperates with relevant departments of WFCMS in level examinations and qualification approvals.

EIC commits itself to promote international exchanges and development of CM education, to improve global CM personnel training, and to accelerate the spread and development of CM sciences in the world.

馬融，醫(yī)學博士、博士生導師、教授、主任醫(yī)師。先后獲得“全國衛(wèi)生系統(tǒng)先進工作者”、“國務院政府特殊津貼專家”、天津市政府授銜“中醫(yī)小兒神經(jīng)內(nèi)科專家”等稱號。